NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

M1 Kliniken AG (XETRA: M12)

 
M12 Technical Analysis
5
As on 21st Nov 2024 M12 STOCK Price closed @ 16.20 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 10.39 & Strong Buy for SHORT-TERM with Stoploss of 7.82 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

M12STOCK Price

Open 16.90 Change Price %
High 17.10 1 Day -1.00 -5.81
Low 16.15 1 Week -0.25 -1.52
Close 16.20 1 Month -0.15 -0.92
Volume 15939 1 Year 8.60 113.16
52 Week High 21.90 | 52 Week Low 7.38
 
XETRA Germany Most Active Stocks
LHAR 2.05 -20.23%
BBVA 5.00 -2.72%
BBVA 5.00 -2.72%
BBVA 5.00 -2.72%
BVBA 0.02 -60.00%
SNH 0.16 6.67%
SNH 0.16 6.67%
SNH 0.16 6.67%
PHIA 31.36 1.92%
PHIA 31.36 1.92%
 
XETRA Germany Top Gainers Stocks
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PAG 0.02 100.00%
PAG 0.02 100.00%
PAG 0.02 100.00%
PAG 0.02 100.00%
 
XETRA Germany Top Losers Stocks
F03 0.56 -99.14%
F03 0.56 -99.14%
F03 0.56 -99.14%
F03 0.56 -99.14%
IQL 0.02 -66.67%
IQL 0.02 -66.67%
EIN3 60.20 -63.95%
EIN3 60.20 -63.95%
EIN3 60.20 -63.95%
LEO 0.04 -63.64%
 
 
M12
Daily Charts
M12
Intraday Charts
Whats New @
Bazaartrend
M12
Free Analysis
 
M12 Important Levels Intraday
RESISTANCE18.03
RESISTANCE17.44
RESISTANCE17.08
RESISTANCE16.72
SUPPORT15.68
SUPPORT15.32
SUPPORT14.96
SUPPORT14.37
 
M12 Forecast November 2024
4th UP Forecast18.24
3rd UP Forecast17.59
2nd UP Forecast17.18
1st UP Forecast16.78
1st DOWN Forecast15.62
2nd DOWN Forecast15.22
3rd DOWN Forecast14.81
4th DOWN Forecast14.16
 
M12 Weekly Forecast
4th UP Forecast17.97
3rd UP Forecast17.40
2nd UP Forecast17.05
1st UP Forecast16.70
1st DOWN Forecast15.70
2nd DOWN Forecast15.35
3rd DOWN Forecast15.00
4th DOWN Forecast14.43
 
M12 Forecast2024
4th UP Forecast45.34
3rd UP Forecast35.99
2nd UP Forecast30.22
1st UP Forecast24.44
1st DOWN Forecast7.96
2nd DOWN Forecast2.18
3rd DOWN Forecast-3.59
4th DOWN Forecast-12.94
 
 
M12 Other Details
Segment EQ
Market Capital 146038016.00
Sector Healthcare
Industry Medical Care Facilities
Offical website >
 
M12 Address
M12
 
M12 Latest News
 
Your Comments and Response on M1 Kliniken AG
 
M12 Business Profile
M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic medicine and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty and Trade. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine, plastic surgery, and cosmetic dermatology, as well as trades in pharmaceutical, biosimilars, and other medical products in the areas of oncology, HIV, rheumatism, neurology, cardiovascular diseases, and narcotics. The company also engages in the acquisition, development, operation, and sale of real estate, primarily in the health care sector. In addition, it offers its products to private customers, doctors, pharmacies, and wholesalers under the M1 Select brand. It operates a network of outpatient specialist centers for beauty treatments; and a specialist surgical clinic centre, as well as 38 specialist centres under the M1 Med Beauty brand. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG. Address: GrĂ¼nauer Strasse 5, Berlin, Germany, 12557
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service